Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency and Safety of ChimeriVax-JE in Toddlers
NCT00735644Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2008
- Primary completion
- May 2009
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Aug 2008; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00735644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735644.